Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin

Australasian Journal of Dermatology

Volumn 51, Issue 4, 2010, Pages 248-253

  Rademaker, Marius ^a  

^a Tristram Clinic   (New Zealand)

Author keywords

acne vulgaris; depression; side effect; teratogenicity

Indexed keywords

ISOTRETINOIN;

ACANTHOSIS NIGRICANS; ACNE VULGARIS; ALOPECIA; ARTICLE; CARDIOMYOPATHY; CHEILITIS; COLD INJURY; DERMATITIS; ECZEMA; ENTERITIS; EPISTAXIS; ERYTHEMA NODOSUM; EYE DISEASE; FACE ERYTHEMA; FATIGUE; FOLLICULITIS; GALLSTONE; GASTROINTESTINAL SYMPTOM; GINGIVA HYPERPLASIA; GRANULOMA; HEADACHE; HEMATURIA; HUMAN; HYPERTHYROIDISM; INFECTION; INSOMNIA; KERATOLYSIS; LIPID BLOOD LEVEL; LIVER FUNCTION TEST; MOOD CHANGE; MOUTH ULCER; MYALGIA; NOCTURNAL ENURESIS; POLYCYTHEMIA; POLYDIPSIA; PREGNANCY; PSORIASIS; PTERYGIUM; ROSACEA; SEBORRHEIC DERMATITIS; SIDE EFFECT; SKIN FRAGILITY; SUICIDAL IDEATION; SUICIDE ATTEMPT; SYNCOPE; THROMBOCYTE COUNT; TONSILLITIS;

ACNE VULGARIS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHEILITIS; CHILD; DERMATOLOGIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ECZEMA; FATIGUE; FEMALE; HUMANS; ISOTRETINOIN; MALE; MIDDLE AGED; MOOD DISORDERS; PREGNANCY, UNPLANNED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 78649270393     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2010.00657.x     Document Type: Article

References (18)

1. Jones H, Blanc D, Cunliffe WJ,. 13-cis retinoic acid and acne. Lancet 1980; 2: 1048 - 9.
2. Farrell LN, Strauss JS, Stranieri AM,. The treatment of severe cystic acne with 13-cis-retinoic acid. Evaluation of sebum production and the clinical response in a multiple-dose trial. J. Am. Acad. Dermatol. 1980; 3: 602 - 11.
3. Cunliffe WJ, Van De Kerkhof PC, Caputo R, et al. Roaccutane treatment guidelines: results of an international survey. Dermatology 1997; 194: 351 - 7.
4. Akyol M, Ozcelik S,. Non-acne dermatologic indications for systemic isotretinoin. Am. J. Clin. Dermatol. 2005; 6: 175 - 84.
5. Rabello-Fonseca RM, Azulay DR, Luiz RR, et al. Oral isotretinoin in photoaging: clinical and histopathological evidence of efficacy of an off-label indication. J. Eur. Acad. Dermatol. Venereol. 2009; 23: 115 - 23.
6. Amichai B, Shemer A, Grunwald MH,. Low-dose isotretinoin in the treatment of acne vulgaris. J. Am. Acad. Dermatol. 2006; 54: 644 - 6.
7. Geissler SE, Michelsen S, Plewig G,. Very low dose isotretinoin is effective in controlling seborrhea. J. Dtsch. Dermatol. Ges. 2003; 1: 952 - 8.
8. Marqueling AL, Zane LT,. Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. Semin. Cutan. Med. Surg. 2007; 26: 210 - 20.
9. Chia CY, Lane W, Chibnall J, et al. Isotretinoin therapy and mood changes in adolescents with moderate to severe acne: a cohort study. Arch. Dermatol. 2005; 141: 557 - 60.
10. WHO collaborating Centre For International Drug Monitoring. Causality Assessment of Suspected Adverse Reactions. Available from URL:. (Accessed 30 Aug 2009.)
11. Bernstein CN, Nugent Z, Longobardi T, et al. Isotretinoin is not associated with inflammatory bowel disease: a population-based case-control study. Am. J. Gastroenterol. 2009; 104: 2774 - 8.
12. Thiboutot D, Gollnick H, Bettoli V, et al. Global alliance to improve outcomes in acne. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J. Am. Acad. Dermatol. 2009; 60 (Suppl. 5): S1 - 50.
13. Larsen TH, Jemec GB,. Acne: comparing hormonal approaches to antibiotics and isotretinoin. Expert Opin. Pharmacother. 2003; 4: 1097 - 103.
14. Dai WS, LaBraico JM, Stern RS,. Epidemiology of isotretinoin exposure during pregnancy. J. Am. Acad. Dermatol. 1992; 26: 599 - 606.
15. Magin P, Pond D, Smith W,. Isotretinoin, depression and suicide: a review of the evidence. Br. J. Gen. Pract. 2005; 55: 134 - 8.
16. McLane J,. Analysis of common side effects of isotretinoin. J. Am. Acad. Dermatol. 2001; 45: S188 - 194.
17. Goldsmith LA, Bolognia JL, Callen JP, et al. American Academy of Dermatology. American Academy of Dermatology Consensus Conference on the safe and optimal use of isotretinoin: summary and recommendations. J. Am. Acad. Dermatol. 2004; 50: 900 - 6.
18. Charakida A, Mouser PE, Chu AC,. Safety and side effects of the acne drug, oral isotretinoin. Expert Opin. Drug Saf. 2004; 3: 119 - 29.